Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1297563rdf:typepubmed:Citationlld:pubmed
pubmed-article:1297563lifeskim:mentionsumls-concept:C0085084lld:lifeskim
pubmed-article:1297563lifeskim:mentionsumls-concept:C0030489lld:lifeskim
pubmed-article:1297563pubmed:issue10lld:pubmed
pubmed-article:1297563pubmed:dateCreated1993-5-4lld:pubmed
pubmed-article:1297563pubmed:abstractTextIn some patients, motor neuron disease (MND) is associated with a paraprotein, raising the question that there may be a relationship between MND and monoclonal gammopathy. We analysed the presence of monoclonal immunoglobulin in the serum from 53 patients with MND using immunofixation in cellulose acetate membrane. The incidence of paraproteins in 6 cases (11.3%) of patients with MND exceeds values found with cellulose acetate membrane supports in reported populations (below 1%), even when age was also considered. Monoclonal components were IgG (33%), IgM (33%) and IgA (33%). In six cases, four showed typical changes of amyotrophic lateral sclerosis and other two patients were spinal progressive muscular atrophy (SPMA) in autopsy. No malignancy was detected in all cases. These results corroborate the concept of a probable association between MND and benign monoclonal gammopathy (plasma cell dyscrasia). A patient with SPMA had transient elevation of IgG-GM1 antibodies. Other five patients with M-proteinemia did not show elevated serum anti GM1 antibodies.lld:pubmed
pubmed-article:1297563pubmed:languagejpnlld:pubmed
pubmed-article:1297563pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1297563pubmed:citationSubsetIMlld:pubmed
pubmed-article:1297563pubmed:statusMEDLINElld:pubmed
pubmed-article:1297563pubmed:monthOctlld:pubmed
pubmed-article:1297563pubmed:issn0009-918Xlld:pubmed
pubmed-article:1297563pubmed:authorpubmed-author:SaitoTTlld:pubmed
pubmed-article:1297563pubmed:authorpubmed-author:ItoHHlld:pubmed
pubmed-article:1297563pubmed:authorpubmed-author:IrieSSlld:pubmed
pubmed-article:1297563pubmed:authorpubmed-author:KowaHHlld:pubmed
pubmed-article:1297563pubmed:issnTypePrintlld:pubmed
pubmed-article:1297563pubmed:volume32lld:pubmed
pubmed-article:1297563pubmed:ownerNLMlld:pubmed
pubmed-article:1297563pubmed:authorsCompleteYlld:pubmed
pubmed-article:1297563pubmed:pagination1146-8lld:pubmed
pubmed-article:1297563pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1297563pubmed:meshHeadingpubmed-meshheading:1297563-...lld:pubmed
pubmed-article:1297563pubmed:meshHeadingpubmed-meshheading:1297563-...lld:pubmed
pubmed-article:1297563pubmed:meshHeadingpubmed-meshheading:1297563-...lld:pubmed
pubmed-article:1297563pubmed:meshHeadingpubmed-meshheading:1297563-...lld:pubmed
pubmed-article:1297563pubmed:meshHeadingpubmed-meshheading:1297563-...lld:pubmed
pubmed-article:1297563pubmed:year1992lld:pubmed
pubmed-article:1297563pubmed:articleTitle[Paraproteinemia and motor neuron disease].lld:pubmed
pubmed-article:1297563pubmed:affiliationDepartment of Neurology, Kitasato University East Hospital.lld:pubmed
pubmed-article:1297563pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1297563pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:1297563pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed